By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are elevated
The body adapts, and weight loss may slow down or stop, even though the medication continues to work in other ways
Results vary, but many people notice appetite changes within the first few weeks
There is a complicating factor that makes tirzepatide particularly interesting from a research standpoint: some case reports and small studies have described improved hair growth in patients using tirzepatide for type 2 diabetes with concurrent androgenetic alopecia
Exploring the causal connection: insights into diabetic nephropathy and gut microbiota from whole-genome sequencing databases
Monitoring your weight and measurements, like waist and hip size, provides valuable insights into body composition changes that may not always be visible on the scale